Sebastiano Battaglia

Author

Roswell Park Comprehensive Cancer Center ORCID

Also Known As

Battaglia, Sebastiano, S Battaglia, S. Battaglia, S., Battaglia, Sebastiano Battaglia

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

Roswell Park Comprehensive Cancer Center Cancer Genetics (United States)University of Chicago University at Buffalo, State University of New York University of Birmingham

About

Sebastiano Battaglia is an author at Roswell Park Comprehensive Cancer Center specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	310
2	Cell Biology	8	8	295
3	Engineering	1	1	16
4	Natural Sciences	1	1	67
5	Cellular Physiology	1	1	43

Sebastiano Battaglia

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
T-cell CX3CR1 expression as a dynamic blood-based biomarker of response to immune checkpoint inhibitors Takayoshi Yamauchi, Toshifumi Hoki, Takaaki Oba, Nature Communications	2021	179
Efficient identification of neoantigen-specific T-cell responses in advanced human ovarian cancer Song Liu, Junko Matsuzaki, Lei Wei, Journal for ImmunoTherapy of Cancer	2019	86
IDO1 Expression in Ovarian Cancer Induces PD-1 in T Cells via Aryl Hydrocarbon Receptor Activation Adaobi Amobi-McCloud, Ravikumar Muthuswamy, Sebastiano Battaglia, Frontiers in Immunology	2021	82
Epigenetic control of a VDR-governed feed-forward loop that regulates p21 ( waf1/cip1 ) expression and function in non-malignant prostate cells James L. Thorne, Orla Maguire, Craig Doig, Nucleic Acids Research Histone ModificationsEpigenetic ChangeMolecular BiologyNon-malignant Prostate CellsCell Cycle	2010	67
Elevated NCOR1 disrupts PPARα/γ signaling in prostate cancer and forms a targetable epigenetic lesion Sebastiano Battaglia, Orla Maguire, James L. Thorne, Carcinogenesis Targetable Epigenetic LesionRetinoic AcidCell CycleCancer BiologyEpigenetics	2010	64
Metabolic adaptation of ovarian tumors in patients treated with an IDO1 inhibitor constrains antitumor immune responses Kunle Odunsi, Feng Qian, Amit A. Lugade, Science Translational Medicine	2022	63
Complete response to anti-PD-L1 antibody in a metastatic bladder cancer associated with novel MSH4 mutation and microsatellite instability Yuanquan Yang, Rohit Jain, Sean T. Glenn, Journal for ImmunoTherapy of Cancer	2020	60
Recruitment of NCOR1 to VDR target genes is enhanced in prostate cancer cells and associates with altered DNA methylation patterns Craig Doig, Priyanka Singh, Vineet K. Dhiman, Carcinogenesis	2012	55
CXCR6 by increasing retention of memory CD8<sup>+</sup> T cells in the ovarian tumor microenvironment promotes immunosurveillance and control of ovarian cancer Ravikumar Muthuswamy, AJ Robert McGray, Sebastiano Battaglia, Journal for ImmunoTherapy of Cancer	2021	55
Oncolytic Maraba virus armed with tumor antigen boosts vaccine priming and reveals diverse therapeutic response patterns when combined with checkpoint blockade in ovarian cancer AJ Robert McGray, Ruea-Yea Huang, Sebastiano Battaglia, Journal for ImmunoTherapy of Cancer	2019	53

Page 1